V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250006832 | 250004820 | 0 | 73.9 | Disease modification (D) | 2015-12-27 | 2016-02-27 | IMATINIB | N | N | 250030399 | RUXOLITINIB |
| 250006833 | 250004820 | 1.74 | 69 | Palliative (P) | null | 2016-02-22 | Rituximab | null | null | 250030399 | METHOTREXATE INTRATHECAL |
| 250006834 | 250004820 | 1.73 | 0 | Palliative (P) | 2017-02-13 | 2017-02-13 | RUXOLITINIB | N | N | 250030399 | RUXOLITINIB |
| 250006835 | 250004821 | 1.58 | 95.2 | null | 2015-11-27 | 2015-11-27 | RUXOLITINIB | 02 | null | 250030408 | RUXOLITINIB |
| 250006836 | 250004821 | null | 52.2 | Palliative (P) | 2014-06-16 | 2014-06-28 | RUXOLITINIB | N | null | 250030408 | RUXOLITINIB |
| 250006837 | 250004822 | 1.57 | null | Palliative (P) | 2014-05-30 | 2016-04-01 | CVP R | N | null | 250030411 | TRIAL |
| 250006838 | 250004823 | 1.65 | null | Palliative (P) | 2013-09-26 | 2013-10-01 | RUXOLITINIB | null | N | 250030412 | PEMETREXED |
| 250006839 | 250004824 | null | 89 | Palliative (P) | 2014-09-22 | 2014-09-22 | RUXOLITINIB | 2 | N | 250030413 | BUSULPHAN |
| 250006840 | 250004825 | 0 | 92.3 | Palliative (P) | 2016-01-29 | 2016-01-29 | RUXOLITINIB | N | N | 250030414 | RUXOLITINIB |
| 250006841 | 250004826 | null | 73.1 | Palliative (P) | 2013-08-30 | 2013-08-30 | Rituximab | N | N | 250030418 | RUXOLITINIB |
| 250006842 | 250004827 | 0 | 41 | Disease modification (D) | null | 2017-07-21 | ANAGRELIDE | N | N | 250030419 | RUXOLITINIB |
| 250006843 | 250004828 | null | 64.9 | Palliative (P) | 2017-09-01 | 2017-09-01 | PEG INTERFERON | 2 | N | 250030420 | RUXOLITINIB |
| 250006844 | 250004829 | 1.53 | 68 | Curative (C) | 2016-11-10 | 2016-11-29 | RUXOLITINIB | N | null | 250030421 | RUXOLITINIB |
| 250006845 | 250004830 | 1.61 | 0 | Palliative (P) | 2013-07-11 | 2013-07-11 | ATG + Busulfan + Fludarabine | N | N | 250030424 | RUXOLITINIB |
| 250006846 | 250004830 | 1.8 | 93 | Adjuvant (A) | 2013-01-28 | 2013-03-11 | BUSULFAN | N | N | 250030424 | RUXOLITINIB |
| 250006847 | 250004831 | 0 | 78 | Palliative (P) | 2014-01-19 | 2014-01-24 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | N | N | 250030433 | RUXOLITINIB |
| 250006848 | 250004832 | 1.6 | 51.4 | Palliative (P) | 2013-09-01 | 2013-09-04 | Bortezomib + Cyclophos + Dex | N | N | 250030438 | PEG INTERFERON |
| 250006849 | 250009617 | null | 55.9 | Palliative (P) | 2015-03-26 | 2015-03-26 | RUXOLITINIB | N | N | 250030439 | RUXOLITINIB |
| 250006850 | 250004833 | 1.5 | 74.9 | Palliative (P) | 2014-10-25 | 2014-10-25 | RUXOLITINIB | N | N | 250030440 | RUXOLITINIB |
| 250006851 | 250004834 | 1.55 | 86.8 | Palliative (P) | 2016-11-15 | 2016-11-15 | ETOPOSIDE + RITUXIMAB | N | N | 250030445 | IMATINIB |
| 250006852 | 250004834 | 1.76 | 95.8 | Disease modification (D) | 2017-08-08 | 2017-08-10 | Azacitidine | 2 | N | 250030445 | FLAG + IDARUBICIN |
| 250006853 | 250004835 | 1.78 | null | Curative (C) | 2014-07-07 | 2014-07-07 | RUXOLITINIB | 02 | N | 250030450 | PEG INTERFERON |
| 250006854 | 250009619 | null | 66.2 | Curative (C) | 2013-08-20 | 2013-08-20 | RUXOLITINIB | 02 | N | 250030453 | IMATINIB |
| 250006855 | 250004836 | null | 0 | Palliative (P) | 2017-11-27 | 2017-12-11 | Busulfan Oral | N | N | 250030455 | AZACITIDINE |
| 250006856 | 250004837 | 1.63 | 0 | Palliative (P) | 2013-06-28 | 2013-06-28 | CHOP R - 21 days | 02 | N | 250030456 | CVP R |
| 250006858 | 250004839 | null | 0 | Disease modification (D) | 2015-03-21 | 2015-03-21 | RUXOLITINIB | N | N | 250030459 | AZACITIDINE |
| 250006859 | 250009620 | 1.73 | 0 | Adjuvant (A) | null | 2014-08-29 | Capecitabine + Oxaliplatin 21day | N | N | 250030460 | ATG + BUSULFAN + FLUDARABINE |
| 250006860 | 250004840 | 0 | 0 | Disease modification (D) | 2014-07-31 | 2014-07-31 | RUXOLITINIB | N | N | 250030464 | BUSULPHAN |
| 250006861 | 250004841 | 1.73 | 58.3 | Curative (C) | 2018-09-03 | 2018-09-03 | Alemtuzumab(INTRAVENOUS) | N | N | 250030467 | RUXOLITINIB |
| 250006863 | 250004843 | 1.65 | null | Palliative (P) | 2018-06-05 | 2018-06-05 | Bendamustine + prednisolone | null | N | 250030469 | RUXOLITINIB |
| 250006864 | 250004844 | 0 | 60 | Adjuvant (A) | 2016-06-25 | 2016-06-25 | CHOP - 21 days | N | N | 250030472 | RUXOLITINIB |
| 250006865 | 250009621 | 1.83 | 90 | Curative (C) | 2014-02-24 | 2014-02-24 | RUXOLITINIB | 02 | N | 250030475 | RUXOLITINIB |
| 250006866 | 250004845 | 1.47 | 66.1 | null | 2013-08-27 | 2013-09-09 | Chlorambucil | null | null | 250030478 | THALIDOMIDE |
| 250006867 | 250004846 | null | 56.4 | Curative (C) | 2017-03-12 | 2017-03-12 | RUXOLITINIB | N | N | 250030482 | RUXOLITINIB |
| 250006868 | 250004847 | null | null | Palliative (P) | 2013-04-26 | 2013-04-26 | PEG INTERFERON | N | N | 250030489 | INTERFERON |
| 250006869 | 250004848 | 1.58 | null | Curative (C) | 2014-05-16 | 2014-05-17 | RUXOLITINIB | 2 | null | 250030490 | RUXOLITINIB |
| 250006870 | 250004849 | 1.8 | 55 | Palliative (P) | 2013-09-04 | 2013-09-07 | RUXOLITINIB | 2 | N | 250030494 | RITUXIMAB |
| 250006871 | 250004850 | 1.88 | null | Disease modification (D) | 2013-12-25 | 2013-12-25 | RUXOLITINIB | N | Y | 250030495 | ATG + BUSULFAN + FLUDARABINE |
| 250006872 | 250004850 | null | 79.5 | Palliative (P) | 2015-07-11 | 2015-07-11 | Vinorelbine (oral) | 01 | N | 250030495 | CAPECITABINE + OXALIPLATIN |
| 250006873 | 250011573 | 1.78 | 59 | Disease modification (D) | 2013-10-01 | 2013-10-01 | CYCLOPHOSPHAMIDE + FLUDARABINE | 2 | N | 250030501 | THALIDOMIDE |
| 250006874 | 250004851 | 1.6 | 99.4 | Curative (C) | 2014-08-15 | 2014-08-15 | RUXOLITINIB | 1 | N | 250030504 | RUXOLITINIB |
| 250006875 | 250004852 | 1.74 | null | Palliative (P) | null | 2016-04-14 | BUSULFAN | N | N | 250030505 | PEG INTERFERON |
| 250006876 | 250009623 | null | 63 | null | 2015-05-24 | 2015-05-24 | null | 02 | null | 250030507 | RITUXIMAB |
| 250006877 | 250004853 | 1.55 | 60.7 | Disease modification (D) | 2017-06-26 | 2017-06-26 | PEG INTERFERON | N | N | 250030509 | INTERFERON |
| 250006878 | 250004854 | 1.57 | null | Curative (C) | 2013-02-12 | 2014-11-12 | Rituximab | Y | N | 250030511 | RITUXIMAB |
| 250006879 | 250004855 | 1.6 | null | Disease modification (D) | 2013-04-23 | 2013-04-24 | Busulfan Oral | 02 | N | 250030515 | TRIAL |
| 250006880 | 250004856 | 1.58 | 61.3 | Disease modification (D) | 2017-10-27 | 2017-11-27 | Rituximab | N | N | 250030520 | NOT MATCHED |
| 250006881 | 250004857 | 0 | 52.2 | Disease modification (D) | 2016-07-23 | 2016-07-26 | Rituximab | N | N | 250030521 | THALIDOMIDE |
| 250006882 | 250004858 | 1.78 | 95 | Adjuvant (A) | 2017-10-27 | 2017-10-29 | RUXOLITINIB | 02 | N | 250030526 | RUXOLITINIB |
| 250006883 | 250004858 | null | 61 | Palliative (P) | 2017-02-15 | 2017-02-18 | Azacitidine | 02 | N | 250030526 | TRIAL |